GEHC or A: Which Is the Better Value Stock Right Now?
GEHC vs. A: Which Stock Is the Better Value Option?
New Strong Buy Stocks for August 15th
TEN, ECO, MOS, GEHC and SBFG have been added to the Zacks Rank #1 (Strong Buy) List on August 15, 2025.
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts
Surmodics delivers third-quarter fiscal 2025 earnings beat with narrower loss, as revenue tops estimates despite lower SurVeil DCB sales.
Tutor Perini and Crocs have been highlighted as Zacks Bull and Bear of the Day
Tutor Perini surges on a 386% earnings beat, record $21.1B backlog, and higher 2025 guidance, while Crocs struggles with tariff uncertainty.
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
AMN Stock Slips Despite Q2 Earnings & Revenue Beat, Margins Down
AMN Healthcare tops second-quarter 2025 earnings and revenue forecasts, but margins and segment sales face continued pressure.
BD Stock Gains in Pre-Market Following Q3 Earnings Beat, Margins Up
BDX tops third-quarter fiscal 2025 earnings and margin estimates, with strong results from its Medical and Interventional segments.
DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands
DVA reports strong second-quarter 2025 results with earnings and revenue beat, along with a boost in gross margin, driven by core operations.
MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand
Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.
HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down
Hims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and subscriber growth.
INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts
Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.
What Makes GE HealthCare ( GEHC ) a New Strong Buy Stock
GE HealthCare (GEHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
OPKO Health reports wider-than-expected second-quarter 2025 loss and revenue decline, but gross margin expands and product sales remain stable.
GEHC vs. BSX: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies ( GEHC Quick QuoteGEHC - ) and Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
GEHC's second-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves with better pricing.
GE HealthCare Technologies ( GEHC ) Q2 Earnings and Revenues Top Estimates
GE HealthCare (GEHC) delivered earnings and revenue surprises of +16.48% and +0.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings?
GEHC leans on Imaging and PDx strength for Q2, but tariff headwinds and margin pressures could test investor confidence.
Valneva ( VALN ) Soars 17.4%: Is Further Upside Left in the Stock?
Valneva (VALN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
3 AI-Driven Medical Device Stocks to Watch in 2025
BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.
SNN vs. GEHC: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew ( SNN Quick QuoteSNN - ) and GE HealthCare Technologies ( GEHC Quick QuoteGEHC - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications
GE HealthCare gains FDA nod to expand Vizamyl's use, unlocking new diagnostic and therapy-monitoring capabilities.
GE HealthCare Stock Slips Despite the Launch of bkActiv S Series
GEHC expands its bkPortfolio with the AI-powered bkActiv S Series to advance ultrasound-guided procedures.
GEHC Stock Declines Despite Expansion in Precision Care Capabilities
GE HealthCare integrates proprietary algorithms into MIM Encore to advance digital imaging and workflow precision.
Why Is Perrigo ( PRGO ) Down 3.1% Since Last Earnings Report?
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Things Nvidia Management Just Said That Build the Buy Case for These 3 Magnificent Hidden AI Stocks
Nvidia's ( NASDAQ: NVDA ) recent earnings report boosted the market and alleviated concerns about any slowdown in artificial intelligence ( AI ) and data-center-related spending. That's great news for Nvidia and other frontline players in the AI/data center industry.
Nvidia Unveils Foundation Models For Humanoids, Eyes 'Era of Robotics' As AI Spend Accelerates - GE HealthCare Techs ( NASDAQ:GEHC ) , GE Aerospace ( NYSE:GE )
Nvidia Corp. NVDA unveiled its robotics strategy during its first-quarter 2025 earnings call on Wednesday, positioning the chipmaker for what executives called the emerging "era of robotics" as artificial intelligence expands beyond data centers into physical applications.
GEHC Stock May Rise Following the Launch of AI-Based CleaRecon DL
GE HealthCare launches CleaRecon DL, an AI-powered 3D imaging tech that enhances cone-beam CT scans by reducing artifacts, improving clarity for better interventional care.
GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use
GEHC's Optison ultrasound agent receives FDA approval for pediatric use, improving echocardiogram clarity and advancing heart diagnostics for children with safer imaging.
Jim Cramer: SoFi Goes To 'New Highs,' Recommends Not Buying This Health Care Stock - Roku ( NASDAQ:ROKU ) , GE HealthCare Techs ( NASDAQ:GEHC )
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes SoFi Technologies, Inc. SOFI, adding that the stock goes to "new highs." To support his view, the company reported quarterly adjusted sales of $770.72 million on April 29, beating analyst estimates of $739.04 million.
GEHC Stock Surges as SIGNA Sprint MRI Redefines 1.5T Imaging Tech
GE HealthCare unveils SIGNA Sprint MRI, a high-performance 1.5T system designed to boost diagnostic accuracy, accelerate imaging, and advance cardiac and cancer care.
Here's Why GE HealthCare Stock Blasted Higher Today
A thawing in the U.S./China trading relationship is excellent news for a company like GE HealthCare Technologies ( NASDAQ: GEHC ) . It's a large exporter to China ( a market management sees as having excellent long-term potential ) and uses Chinese-sourced components in its products.
MedTechs Adjust 2025 Outlook Amid Tariffs: What Investors Need to Know
Most of the MedTech players have adjusted their 2025 forecasts in response to rising tariff pressure.
Here's Why GE HealthCare Stock Sank in April
Shares in medical equipment company GE HealthCare Technologies ( NASDAQ: GEHC ) declined by 12.9% in April, according to data provided by S&P Global Market Intelligence. The key reason for the decline comes from the "Liberation Day" tariffs announced by President Donald Trump at the start of the ...
GE HealthCare Q1 Earnings & Sales Beat Estimates, Net Margin Rises
GEHC's first-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.
GE HealthCare Technologies ( GEHC ) Q1 Earnings and Revenues Top Estimates
GE HealthCare (GEHC) delivered earnings and revenue surprises of 10.99% and 2.57%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Zynex Inc. ( ZYXI ) Reports Q1 Loss, Lags Revenue Estimates
Zynex (ZYXI) delivered earnings and revenue surprises of -65% and 15.63%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy, Sell, or Hold GE Healthcare Before Q1 Earnings?
GEHC Q1 results are likely to reflect strong growth in Imaging, Ultrasound, and AI, fueled by robust procedure volumes and global partnerships despite China headwinds.
Stay Ahead of the Game With GE HealthCare ( GEHC ) Q1 Earnings: Wall Street's Insights on Key Metrics
Besides Wall Street's top -and-bottom-line estimates for GE HealthCare (GEHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Here's Why You Should Hold the GEHC Stock in Your Portfolio for Now
GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
GE HealthCare ( GEHC ) Surges 10.6%: Is This an Indication of Further Gains?
GE HealthCare (GEHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why GE HealthCare Technologies Stock Fell Today
Shares in GE HealthCare Technologies ( NASDAQ: GEHC ) were down 9.5% at 1 p.m. today. The decline follows the U.S.'s wide-scale implementation of tariffs. GE HealthCare is a truly global company, and the tariff actions will negatively impact its business.The company generated about $9 billion in ...
Vital Signs Monitoring Devices Market Set to Reach USD 66.82 Billion by 2030, Growing at a CAGR of 12.7% - Exclusive Report by The Insight Partners
US & Canada, April 02, 2025 ( GLOBE NEWSWIRE ) -- US & Canada, Mar, 21, 2025 ( GlobeNewswire ) -- According to a comprehensive report from The Insight Partners, "Vital Signs Monitoring Devices Market Size and Forecasts ( 2020 - 2030 ) , Global and Regional Share, Trends, and Growth Opportunity ...
GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm
GE HealthCare aims to expand its existing footprint and offerings in Japan, as well as enhance patient access to next-generation radiopharmaceuticals via its latest acquisition.
GEHC Stock May Rise as Revolution Vibe CT Enhances Imaging Tech
GE HealthCare introduces Revolution Vibe CT, a cutting-edge imaging system designed to enhance diagnostic precision, improve workflow efficiency, and expand accessibility.
GE HealthCare's Latest Product Launch to Boost Cardiology Care
GEHC's latest commercial launch of Flyrcado and the grant of pass-through status by CMS aim to serve a wider patient pool across the United States.
Down 13% to 41%, These 3 Nvidia Partners Are Raging Buys
Data center equipment maker Vertiv ( NYSE: VRT ) , healthcare technology specialist GE HealthCare Technologies ( NASDAQ:GEHC ) , and electrical protection and connection products company nVent Electric ( NYSE: NVT ) are all Nvidia collaborators, and they all focus on the AI growth opportunity.
3 Hidden Gem AI Stocks to Buy That You Might Never Have Thought Of
Many top artificial intelligence ( AI ) stocks have come into the spotlight and produced monster gains in recent years. These gains have been great for their longer-term shareholders, of course, but they've also left the stocks trading at expensive and forward-looking valuations -- levels high ...
GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis
GE HealthCare aims to deliver optimal outcomes with its innovative, patient-friendly and efficient AI-driven technology via its latest product offering.
Here's Why You Should Hold GEHC Stock in Your Portfolio for Now
GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
GEHC Stock Gains Following Cardiology Solutions Portfolio Expansion
GE HealthCare aims to enhance efficiency and precision care for multiple types of cardiac procedures through the introduction of improved interventional solutions.
